Mineral bone disorder (MBD) is a tricky systemic syndrome in chronic kidney disease- (CKD) patients, characterized by bone turnover disturbance, vitamin D deficiency, abnormal metabolism of calcium and phosphate, high circulating levels of intact parathyroid hormone (iPTH), and extra-osseous calcification in the vessel wall and soft tissue [1]. Here, PTH is linked to chronic kidney disease.